Literature DB >> 11577447

Risk factors reducing blood transfusion requirements in pediatric open heart surgery after introduction of vacuum assisted circuits.

K Nakanishi1, T Shichijo, G Kato, M Nakai, O Oba.   

Abstract

OBJECTIVES: Open heart surgery without homologous blood transfusion remains difficult in children. The introduction of vacuum-assisted cardiopulmonary bypass circuits to reduce priming volume for pediatric patients has improved the percentage of transfusion-free operations. We retrospectively analyzed blood transfusion risk factors to further reduce blood transfusion requirements after vacuum-assisted circuit introduction.
METHODS: From March 1995 to June 1996, 49 patients weighing between 5 and 20 kg underwent cardiac surgery with cardiopulmonary bypass at our institution, excluding hospital deaths. We retrospectively analyzed risk factors influencing blood use in 37 patients with no blood priming in cardiopulmonary bypass after introducing a vacuum-assisted system. Factors selected for univariate analysis were age, body weight, cyanosis, preoperative Hb, operation time, cardiopulmonary bypass time, aortic cross-clamping time, and intraoperative and postoperative bleeding volume. Correlation between total bleeding volume/body weight and cardiopulmonary bypass time was studied by regression analysis.
RESULTS: As risk factors, univariate analysis identified cyanotic disease, longer operation time (> 210 minutes), longer cardiopulmonary bypass time (> 90 minutes), longer aortic cross-clamping time (> 45 minutes), greater intraoperative bleeding volume/body weight (> 4 ml/kg), and greater postoperative bleeding volume/body weight (> 15 ml/kg). Regression analysis showed a significant positive correlation between total bleeding volume/body weight and cardiopulmonary bypass time.
CONCLUSIONS: Cyanotic disease and long bypass time are risk factors in reducing blood transfusion requirements in pediatric open heart surgery after introduction of vacuum-assisted circuits. Further efforts are needed, however, to reduce blood transfusion requirements, particularly in these children.

Entities:  

Mesh:

Year:  2001        PMID: 11577447     DOI: 10.1007/bf02913533

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  18 in total

Review 1.  Reduction in requirements for allogeneic blood products: nonpharmacologic methods.

Authors:  J F Hardy; S Bélisle; G Janvier; M Samama
Journal:  Ann Thorac Surg       Date:  1996-12       Impact factor: 4.330

2.  Scheduled autologous blood donation at the time of cardiac catheterization in infants and children.

Authors:  K Fukahara; A Murakami; T Ueda; Y Doki; S Tsubata; F Ichida; T Misaki
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

3.  Safe limits of hemodilution in cardiopulmonary bypass.

Authors:  Y Kawashima; Z Yamamoto; H Manabe
Journal:  Surgery       Date:  1974-09       Impact factor: 3.982

4.  Hemostasis in cyanotic congenital heart disease.

Authors:  H Ekert; G S Gilchrist; R Stanton; D Hammond
Journal:  J Pediatr       Date:  1970-02       Impact factor: 4.406

5.  Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery.

Authors:  G D Williams; S L Bratton; C Ramamoorthy
Journal:  Anesth Analg       Date:  1999-07       Impact factor: 5.108

6.  Vacuum-assisted venous return in pediatric cardiopulmonary bypass.

Authors:  R Berryessa; R Wiencek; J Jacobson; D Hollingshead; K Farmer; G Cahill
Journal:  Perfusion       Date:  2000-01       Impact factor: 1.972

7.  Predicting and treating coagulopathies after cardiopulmonary bypass in children.

Authors:  B E Miller; T Mochizuki; J H Levy; J M Bailey; S R Tosone; V K Tam; K R Kanter
Journal:  Anesth Analg       Date:  1997-12       Impact factor: 5.108

8.  Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery.

Authors:  G D Williams; S L Bratton; E C Riley; C Ramamoorthy
Journal:  J Cardiothorac Vasc Anesth       Date:  1999-08       Impact factor: 2.628

9.  Cardiac operation for congenital heart disease in children of Jehovah's Witnesses.

Authors:  C E Henling; M J Carmichael; A S Keats; D A Cooley
Journal:  J Thorac Cardiovasc Surg       Date:  1985-06       Impact factor: 5.209

10.  Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study.

Authors:  F Herynkopf; F Lucchese; E Pereira; R Kalil; P Prates; I A Nesralla
Journal:  J Thorac Cardiovasc Surg       Date:  1994-09       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.